Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2026-09-01 16:38:50 ET · period of report 2026-08-28 · accession 0001918845-26-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-01 16:38 | 2026-08-28 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +679 | 52.5K | +1% | +$5,459 |
| DT | 2026-09-01 16:38 | 2026-08-28 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -679 | 51.8K | -1% | -$13.6K |
| DT | 2026-09-01 16:38 | 2026-08-28 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $0.00 | -679 | 113.7K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | M | A | 679 | $8.04 | 52,455 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. |
| 2 | Common | Common Stock | 2026-08-28 | S | D | 679 | $20.00 | 51,776 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-28 | M | D | 679 | $0.00 | 113,734 | D | $8.04 · — to 2035-01-28 | 679 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. (F2) The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on each such vesting date. |